Domain Informations
Pepaxto.com lookup results from whois.corporatedomains.com server:
- Domain created: 2019-05-06T09:00:05Z
- Domain updated: 2026-05-02T05:05:49Z
- Domain expires: 2027-05-06T09:00:05Z 0 Years, 306 Days left
- Website age: 7 Years, 58 Days
- Registrar Domain ID: 2387870926_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- DNS1.CSCDNS.NET
- DNS2.CSCDNS.NET
Network
- inetnum : 40.74.0.0 - 40.125.127.255
- name : MSFT
- handle : NET-40-74-0-0-1
- status : Direct Allocation
- created : 1998-07-10
- changed : 2025-06-10
- desc : To report suspected security issues specific to traffic emanating from Microsoft online services, including the distribution of malicious content or other illicit or illegal material through a Microsoft online service, please submit reports to:,* https://cert.microsoft.com.,For SPAM and other abuse issues, such as Microsoft Accounts, please contact:,* [email protected].,To report security vulnerabilities in Microsoft products and services, please contact:,* [email protected].,For legal and law enforcement-related requests, please contact:,* [email protected],For routing, peering or DNS issues, please,contact:,* [email protected]
Owner
- organization : Microsoft Corporation
- handle : MSFT
- address : Array,Redmond,WA,98052,US
Technical support
- handle : MRPD-ARIN
- name : Microsoft Routing, Peering, and DNS
- phone : +1-425-882-8080
- email : [email protected]
Abuse
- handle : MAC74-ARIN
- name : Microsoft Abuse Contact
- phone : +1-425-882-8080
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 40.112.69.156
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
Site Inspections
Port Scanner (IP: 40.112.69.156)
Spam Check (IP: 40.112.69.156)
Recent Searched Sites
› Akairin.com (13 seconds ago) / US
› Preferredcareapplications.entirehr.com.au (12 seconds ago) / US
› Lubemonitor.shell.com (3 seconds ago) / US
› Srl.or.kr (0 seconds ago) / KR
› Pixilog.com (2 seconds ago) / US
› Falconheadaustin.com (8 seconds ago) / US
› Atode.cc (28 seconds ago) / JP
› Renarms.com (7 seconds ago) / US
› Ligisrl.com (4 seconds ago) / IT
› Pepaxto.com (1 seconds ago) / IE
› Proxima-terminalezorg.nl (24 seconds ago) / DE
› H5.thepaper.cn (7 seconds ago) / CN
› Intra.elandwelfare.or.kr (1 seconds ago) / KR
› Telecarecorp.com (4 seconds ago) / US
› File.cna.com.br (4 seconds ago) / BR
› Oriens-ew.com (14 seconds ago) /
› Ser.msu.edu (6 seconds ago) / US
› Musicow.com (11 seconds ago) / KR
› Mpljogos.com (25 seconds ago) / US
› Rallycu.com (9 seconds ago) / US
Websites Listing
We found Websites Listing below when search with pepaxto.com on Search Engine
FDA issues alert about clinical trials results for Pepaxto
2021-08-24 · Email; Print [7/28/2021] FDA is alerting patients and health care professionals that a clinical trial (OCEAN, Study OP-103) evaluating Pepaxto (melphalan flufenamide) with dexamethasone to treat ...
Fda.govOncopeptides’ PEPAXTO® Receives a Permanent J-Code ...
2021-08-16 · E-mail: [email protected] Cell phone: 508-654-2277 . About Oncopeptides. Oncopeptides is a global biotech company committed to developing targeted therapies for patients facing hard-to-treat hematological diseases. Oncopeptides has one U.S. FDA approved product, PEPAXTO ® (melphalan flufenamide), which is approved for some …
Oncopeptides-us.comPepaxto® (melphalan flufenamide) Medication ...
Pepaxto® (melphalan flufenamide) Medication Precertification Request Aetna Precertification Notification . Phone: 1-866-752-7021 . FAX: 1-888-267-3277 . For Medicare Advantage Part B: Phone: 1-866-503-0857 . FAX: 1-844-268-7263 (All fields must be completed and legible for precertification review.) Please indicate: Start of treatment: Start ...
Aetna.comDailyMed - PEPAXTO- melphalan flufenamide injection ...
PEPAXTO is a white to off-white lyophilized powder for reconstitution (after reconstitution the solution is clear and colorless to light yellow) supplied in a 50 mL single dose vial containing 20 mg melphalan flufenamide. Each 20 mg vial is packaged in a single carton (NDC 73657-020-01).
Dailymed.nlm.nih.govOncopeptides' PEPAXTO ® Receives a Specific C-Code and ...
2021-07-01 · PEPAXTO in combination with dexamethasone was approved by the FDA under accelerated approval on February 26, ... E-mail: [email protected]. Cell phone: 508-654-2277. This information ...
Wfmz.comFDA Alert for Pepaxto (melflufen) in Multiple Myeloma ...
2021-07-29 · FDA has also suspended enrollment in other ongoing Pepaxto clinical trials.” “Patients receiving clinical benefit from Pepaxto may continue treatment in the OCEAN trial provided they are informed of the risks and sign a revised written informed consent.” “FDA continues to evaluate the OCEAN trial results and may hold a future public meeting to discuss …
Myelomacrowd.orgPepaxto’s Accelerated Approval In Myeloma May Sink On ...
Please enter a valid e-mail address Please make sure you have filled out all fields Please make sure you have filled out all fields Subject: Pepaxto’s Accelerated Approval In Myeloma May Sink On OCEAN Trial's Adverse Survival Data Add a personalized message to your email. Cancel. Send. Please Note: Only individuals with an active subscription will be able to access the full …
Pink.pharmaintelligence.informa.comFDA approves Oncopeptides' PEPAXTO® ( melphalan ...
2021-02-26 · FDA approves Oncopeptides' PEPAXTO® ( melphalan flufenamide) for patients with relapsed or refractory multiple myeloma February 26, 2021, 6:32 PM EST SHARE THIS ARTICLE
Bloomberg.comOncopeptides withdraws Pepaxto® in US, scale down ...
2021-10-22 · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support
Bloomberg.comHow to pronounce Pepaxto | HowToPronounce.com
3 /5. (1 Vote) Very easy. Easy. Moderate. Difficult. Very difficult. Thanks for your vote! Pronunciation of Pepaxto with 1 audio pronunciations.
Howtopronounce.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| fromentdynamometers.com | godaddy.com | -3 Years, -117 Days |
| metropolismoving.com | godaddy.com | -3 Years, -159 Days |
| misscobb.com | tucows.com | -4 Years, -4 Days |
| 3dsexfree.com | danesconames.com | -3 Years, -230 Days |
| commonvisionblox.com | united-domains.de | -3 Years, -339 Days |
| pony4.bike | key-systems.net | -4 Years, -2 Days |
| iphey.com | godaddy.com | -4 Years, -52 Days |
| playform.io | gandi.net | -4 Years, -77 Days |
| p10.fitness | godaddy.com | -3 Years, -272 Days |
| workspace-technology.com | register.it | -3 Years, -16 Days |